Voya Investment Management LLC Ab Cellera Biologics Inc. Call Options Transaction History
Voya Investment Management LLC
- $86.1 Billion
- Q1 2024
Call Options
0 transactions
Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
---|
Others Institutions Holding ABCL
# of Institutions
170Shares Held
120MCall Options Held
264KPut Options Held
254K-
Baker Bros. Advisors LP New York, NY27.5MShares$76.2 Million1.58% of portfolio
-
Baillie Gifford & CO23.2MShares$64.2 Million0.08% of portfolio
-
Capital World Investors Los Angeles, CA8.35MShares$23.1 Million0.01% of portfolio
-
Credit Suisse Ag Zurich, V84.55MShares$12.6 Million0.02% of portfolio
-
Orbimed Advisors LLC San Diego, CA4.18MShares$11.6 Million0.43% of portfolio
About AbCellera Biologics Inc.
- Ticker ABCL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 285,139,008
- Market Cap $790M
- Description
- AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...